NOI HT941026N0064 Reagents and Maintenance Service for Flow Cytometry Instruments.docx

DOCX document 29 KB Posted

Attached to
Reagents and Maintenance Service for Flow Cytometry Instruments
Solicitation number
HT941026N0064
Issued by

About this file

This is a Notice of Intent to award a sole source purchase order contract for reagents and maintenance services for flow cytometry instruments at Madigan Army Medical Center's Pathology Department. The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division - West intends to award a firm-fixed price contract to Beckman Coulter, Inc. (UEI: Z4DRFM3LMJB8, CAGE: 80740) located in Brea, California under FAR 6.302-1 based on a determination that only one source can meet the Government's specialized requirements. The NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing) with a business size standard of 1,250 employees, and the PSC is 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits, and Sets).

The requirement encompasses reagents and testing materials necessary for flow cytometry testing using Government-owned Navios 10 analyzers and TQ Prep workstations, along with maintenance, service, and training support. The procurement includes approximately 50 different reagent and supply line items with quantities ranging from 1 to 20 units, including specialized antibodies, cell tubes, control materials, and sheath fluid. The contract delivery location is Madigan Army Medical Center, Building 9040A, Room G, Tacoma, Washington 98431, with a delivery deadline of September 30, 2027. Interested vendors may submit capability statements not exceeding eight 8.5 by 11-inch pages with 10-point font minimum, demonstrating capability to perform the required work. The closing date for challenges to this sole source determination is June 1, 2026 at 10:00 a.m. Pacific Time, with submissions directed to Jason Willey (jason.d.willey.civ@health.mil) and Tracy M. Robinson (tracy.m.robinson18.civ@health.mil).

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Notice of Intent to Sole Source HT941026N0064

THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE PURCHASE ORDER CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES.

The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division - West (HCD-W), Echo Branch intends to negotiate and award a firm-fixed price purchase order (PO) contract for the provision of all services, materials, and equipment necessary to provide required Reagents and Maintenance Service for Flow Cytometry Instruments for Madigan Armey Medical Center, Pathology Department in accordance with Federal Acquisition Regulation (FAR) 6.302-1 Sole Source acquisitions and FAR RFO 12.102 (a) only one source being available to meet the Government’s needs, to:

Beckman Coulter, Inc 250 Kraemer Blvd Brea, CA 92821-6232

UEI: Z4DRFM3LMJB8

CAGE: 80740

The North American Industry Classification System (NAICS) code for this requirement is 325413 – In-Vitro Diagnostic Substance Manufacturing; the business size standard is 1,250 (# of employees). The Product Service Code (PSC) is 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits, and Sets. The requirement is for Reagents and Maintenance Service contract for Madigan Armey Medical Center. The items being purchased are reagents and testing materials necessary to perform flow cytometry testing using Government-owned Navios 10 analyzer and TQ Prep workstation, as well as maintenance, service, and training on the analyzers for the Department of Pathology, Core Laboratory Services at Madigan Army Medical Center, Joint Base Lewis-McChord, WA. Flow cytometry is a critical tool used to specifically characterize and identify types of white blood cells, and any alteration in that cell type that may be responsible for the onset of infectious diseases, autoimmune disorders or immunodeficiencies.

Requirement DescriptionProduct NumberQuantity
Anti-Kappa-FITC (Goat Polyclonal), 2ml ASR
C15623
2
Anti-Lambda-PE (Goat Polyclonal), 2ml ASR
C15189
2
FMC7-FITC, 1ML, ASR
IM1364U
2
MYELORPEROXIDASE-RPE, 2ML, ASR
IM3455U
2
7-AAD Viability Dye 150t CE
A07704
4
CD1a-APC , 1ML, ASR
IM3645
2
Anti-TdT (POOL)-FITC, 1ML, ASR
IM3524U
2
CD2-Pacific Blue, 0.5ML ASR
B09685
2
CD3-ECD, 1ML, ASR
IM2705U
2
CD3-FITC, 2ML, ASR
IM1281U
2
CD4-APC-Alexa Fluor 700, 0.5ML ASR
B10824
2
CD5-PC5.5, 0.5ML ASR
A70203
2
CD7-PC7, 1ML ASR
A46526
2
CD10-PC7, 1ML ASR
A46527
2
CD11c-APCA700, 50t, ASR
B43304
2
CD14-PC7, 1ML ASR
A22331
2
CD16-APC, 0.5ML ASR
B00845
2
CD19-APC, 1ML, ASR
IM2470U
4
CD20-ECD, 1ML, ASR
IM3607U
4
CD22-RPE, 2ML, ASR
IM1835U
2
CD23-RPE, 2 ML ASR
A33099
2
CD25-APC-Alexa Fluor 750, 0.5ML ASR
B13979
2
CD26-RPE, 2ML, ASR
IM2724
2
CD30-APC, 0.5ML ASR
A87939
2
CD33-PC5.5, 0.5ML ASR
A70198
2
CD34-APC-Alexa Fluor 750, 0.5ML ASR
A89309
2
CD38-APC-Alexa Fluor 700, 0.5ML ASR
B23489
2
CD45-Krome Orange, 1ML, AS
A96416
4
CD56-PC7, 1ML ASR
A51078
2
CD81-Pacific Blue, 0.5ML ASR
B19717
2
CD79a-PC5.5, 50t, ASR
B42018
2
CD103-FITC, 2ML, ASR
IM1856U
2
CD117-ECD, 0.5ML ASR
B38307
2
CD123-PC5.5, 0.5ML ASR
B20022
2
CD138-PC5.5,0.5ML ASR
A98835
2
CD45-FITC/CD56-PE/CD19-ECD/CD3-PC5
6607073
8
TETRA 45/4/8/3
6607013
8
FP,FLOW CHECK PRO IVD 3 X 10 ML KIT
A63493
7
ISOFLOW(TM) EPICS SHEATH FL,10
8546859
20
FP, FLOW SET PRO IVD 3 X 10 ML KIT
A63492
7
IMMUNO-TROL Low Cells
6607098
6
IMMUNO-TROL Cells
6607077
6
IntraPrep Permeabilization Reagent 50t CE
A07802
2
ClearLLab 10C B Cell Tube
B96805
15
ClearLLab 10C T Cell Tube
B96806
15
ClearLLab 10C M1 Cell Tube
B96807
6
ClearLLab 10C M2 Cell Tube
B96808
6
PT Navios 3L 10C Service Contract
B89707
1
CD57-FITC, 2ML, ASR
IM0466U
2
IMMUNOPREP Reagent System
7546999
12
CD8-Pacific Blue, 0.5ML ASR
A82791
2

Delivery Location:

MADIGAN ARMY MEDICAL CENTER

Bldg. 9040A Rm. G 3803 Tacoma, 98431

Delivery:

On or before: 9/30/2027

Based on market research and previous acquisition history, it has been determined that Beckman Coulter, Inc is the only source that can meet the Government’s specialized requirement.

This notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Capability statements shall not exceed six (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order.

If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to Jason Willey at jason.d.willey.civ@health.mil and Tracy M. Robinson at tracy.m.robinson18.civ@health.mil. The closing date for challenges is no later than 10:00 a.m. (Pacific Time), 1 June 2026

NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.

File details come from the government source that posted it. Updated .